Literature DB >> 7573306

Macular epiretinal membrane formation and treated retinal breaks.

B R Saran1, A J Brucker.   

Abstract

PURPOSE: We sought to determine the incidence of macular epiretinal membrane formation in eyes treated for retinal breaks after three different modalities of treatment: laser photocoagulation, cryotherapy, or both.
METHODS: We reviewed the charts of 262 consecutive patients with a diagnosis of retinal tears and included 205 patients who had more than six months of follow-up.
RESULTS: One hundred ninety-five patients were treated. One hundred seventy of these patients had retinal breaks in one eye and 25 patients had breaks in both eyes, for a total of 220 treated eyes. Cryopexy was applied in 125 eyes, laser retinopexy in 73 eyes, and both modalities in 22 eyes. Macular epiretinal membranes developed in a total of 26 eyes: 12 in the cryopexy group, ten in the laser-treated group, and four in the dual modality group. No statistically significant difference, at a level of P < or = .01, was seen in the rate of epiretinal membrane formation between the different treatment modalities. No statistically significant difference, at a level of P < or = .01, was seen in the rate of epiretinal membrane formation in the presence or absence of vitreous hemorrhage or in the type of precedent retinal break.
CONCLUSIONS: After treatment of retinal breaks with laser photocoagulation and cryotherapy, no statistically significant difference in the incidence of macular epiretinal membrane formation was demonstrated.

Entities:  

Mesh:

Year:  1995        PMID: 7573306     DOI: 10.1016/s0002-9394(14)72662-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Treated retinal breaks: clinical course and outcomes.

Authors:  Robert B Garoon; William E Smiddy; Harry W Flynn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-09       Impact factor: 3.117

2.  Retinal function and PKC alpha expression after focal laser photocoagulation.

Authors:  Karin Gjörloff Wallentén; Malin Malmsjö; Sten Andréasson; Angelica Wackenfors; Kristina Johansson; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-17       Impact factor: 3.117

3.  Ranibizumab for idiopathic epiretinal membranes: A retrospective case series.

Authors:  Marwan A Abouammoh; Michel J Belliveau; David R P Almeida; Jeffrey S Gale; Sanjay Sharma
Journal:  Saudi J Ophthalmol       Date:  2013-01-31

4.  Primary retinopexy in preventing retinal detachment in a tertiary eye hospital: a study of 1157 eyes.

Authors:  George Moussa; Emma Samia-Aly; Soon Wai Ch'ng; Kim Son Lett; Arijit Mitra; Ajai K Tyagi; Ash Sharma; Walter Andreatta
Journal:  Eye (Lond)       Date:  2021-05-25       Impact factor: 4.456

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.